Skip to main content
. 2022 Dec 7;2022(12):CD015477. doi: 10.1002/14651858.CD015477
Study  Intervention name Results Unit of analysis Time point Type of assay  Population
GMT (95% CI) GMR (95% CI)
Heterologous booster versus homologous booster
Li 2021a
 
CoronaVac/Ad5 booster 3090.10 (2636.10 to 3622.30) 8.37 (6.52 to 10.75) Not reported 14 days after boost ELISA 18–59 years
CoronaVac/CoronaVac boost 369 (304.20 to 447.50)